Rosales-Reynoso MA, Barros-Núñez P

Language: Spanish
References: 6
Page: 271-273
PDF size: 39.48 Kb.

ABSTRACT

Huntington’s disease (HD) is a neurological degenerative disorder, inherited by an autosomal dominant mode, and caused by a CAG triplet expansion coding for a poly-glutamine sequence in the huntingtin protein. HD affects 5-10 in 100 000 individuals from Caucasian population. Clinically patients display motor, cognitive and psychological impairment, and death within 10-15 years. Concrete advances have been achieved in the knowledge of the mutational mechanism, alteration of the protein product and their neuropathological effects. A number of tests such as PCR with or without DNA modification, Southern blot and mixed methods are analyzed. We describe their characteristics and effectiveness for the molecular diagnosis of HD.

REFERENCES

1. Hayden MR, Fremer B. Huntington’s disease. En: Scriver CR, Sly WS, editors,The metabolic & molecular bases of inherited disease, 8a. edition. McGraw-Hill Professional; 2000, pp. 5677-5701.

2. Landles C, Bates G. Huntingtin and the molecular pathogenesis of Huntington disease. EMBO 2004;5:958-963.

3. Potter NT, Spector EB, Prior TW. Technical standars and guidelines for Huntington disease testing. Genet Med 2004;6:61-65.

4. Valdés JM, Tagle DA, Elmer LW, Collins F. A simple non-radioactive method for diagnosis of Huntington’s disease. Hum Mol Genet 1993;2:633-634.

5. Panagopoulos I, Lassen C, Kristoffersson U, Aman P. A novel PCR- based Approach for the detection of the Huntington disease associated trinucleotide repeat expansion. Hum Mut 1999;13:232-236.

6. Rosales-Reynoso MA, Alonso-Vilatela E, Macías-Ojeda R, Arce-Rivas A, Sandoval L, Troyo-Sanromán R, et al. PCR approach for detection of fragile X syndrome and Huntington disease based on modified DNA: limits and utility. Genet Test 2007;11:153-159.